Related resources
Full-text held externally
- DOI: 10.1259/bjr/15917261
Search for item elsewhere
University researcher(s)
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials.
Leach, M, Brindle, K, Evelhoch, J, Griffiths, J, Horsman, M, Jackson, A, Jayson, G, Judson, I, Knopp, M, Maxwell, R, McIntyre, D, Padhani, A, Price, PM, Rathbone, R, Rustin, G, Tofts, P, Tozer, G, Vennart, W, Waterton, JC, Williams, S, Workman, P
Br J Radiol. 2003;76 Spec No 1:S87-91.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:
Full-text held externally
- DOI: 10.1259/bjr/15917261
Keyword(s)
Drug Design; Humans; Reproducibility of Results; Research Support, Non-U.S. Gov't; blood supply: Neoplasms; drug therapy: Neovascularization, Pathologic; methods: Clinical Trials; methods: Magnetic Resonance Angiography; therapeutic use: Angiogenesis Inhibitors